HealthStream, Inc. (NASDAQ:HSTM – Get Free Report) CFO Scott Alexander Roberts sold 9,500 shares of the firm’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $32.26, for a total transaction of $306,470.00. Following the transaction, the chief financial officer owned 29,160 shares of the company’s stock, valued at approximately $940,701.60. This trade represents a 24.57% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
HealthStream Price Performance
NASDAQ HSTM opened at $28.89 on Monday. The company’s 50 day simple moving average is $31.20 and its 200 day simple moving average is $25.83. HealthStream, Inc. has a 12 month low of $19.50 and a 12 month high of $35.60. The company has a market capitalization of $844.17 million, a P/E ratio of 41.27, a PEG ratio of 3.01 and a beta of 0.45.
HealthStream (NASDAQ:HSTM – Get Free Report) last released its earnings results on Monday, November 2nd. The technology company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.16 by $0.02. The business had revenue of $83.31 million during the quarter, compared to analyst estimates of $82.24 million. HealthStream had a net margin of 6.25% and a return on equity of 6.37%. On average, analysts anticipate that HealthStream, Inc. will post 0.80 earnings per share for the current year.
HealthStream Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Stockholders of record on Monday, November 16th will be given a dividend of $0.0350 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Monday, November 16th. HealthStream’s dividend payout ratio is 20.00%.
More HealthStream News
Here are the key news stories impacting HealthStream this week:
- Positive Sentiment: Buy rating upgrade: Zacks upgraded HSTM to Rank #2 (Buy), citing improving earnings prospects, which could support investor optimism. Zacks article
- Positive Sentiment: Raised guidance: HealthStream lifted its outlook, a potentially positive sign for expected business performance, although the article raises the question of whether prior gains already reflect the news. Yahoo Finance article
- Neutral Sentiment: Analyst views remain cautious: Canaccord Genuity raised its price target to $32 from $29 but maintained a Hold rating; Craig Hallum also moved its rating to Hold. These calls suggest limited conviction despite the higher target. Canaccord rating information Craig Hallum rating article
- Negative Sentiment: Multiple insider sales: On November 5, EVP Michael Manning Collier, CFO Scott Alexander Roberts, Director Deborah Tate and EVP Kevin O’Hara sold a combined 38,081 shares. Each reduced their individual holdings, a cluster of transactions that may weigh on sentiment, though insider sales alone do not establish a change in the company’s outlook. Collier SEC filing Roberts SEC filing Tate SEC filing O’Hara SEC filing
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the company. Citigroup reaffirmed a “market perform” rating on shares of HealthStream in a research report on Tuesday, October 27th. Freedom Capital upgraded HealthStream to a “hold” rating in a research report on Tuesday, October 13th. Craig Hallum cut HealthStream from a “buy” rating to a “hold” rating and set a $40.00 price target on the stock. in a research note on Tuesday, November 3rd. Canaccord Genuity Group boosted their price objective on HealthStream from $29.00 to $32.00 and gave the stock a “hold” rating in a report on Wednesday, November 4th. Finally, Weiss Ratings upgraded HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. One equities research analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, HealthStream presently has an average rating of “Hold” and a consensus price target of $36.00.
Check Out Our Latest Research Report on HealthStream
Hedge Funds Weigh In On HealthStream
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in HealthStream during the 2nd quarter worth about $111,184,000. Dimensional Fund Advisors LP increased its holdings in shares of HealthStream by 6.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,456,043 shares of the technology company’s stock valued at $30,156,000 after purchasing an additional 87,177 shares during the period. Copeland Capital Management LLC increased its holdings in shares of HealthStream by 43.8% in the 1st quarter. Copeland Capital Management LLC now owns 1,276,739 shares of the technology company’s stock valued at $26,441,000 after purchasing an additional 389,186 shares during the period. Renaissance Technologies LLC lifted its position in shares of HealthStream by 0.5% in the first quarter. Renaissance Technologies LLC now owns 477,848 shares of the technology company’s stock worth $9,896,000 after purchasing an additional 2,380 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its position in shares of HealthStream by 21.1% in the first quarter. Arrowstreet Capital Limited Partnership now owns 377,945 shares of the technology company’s stock worth $7,827,000 after purchasing an additional 65,806 shares in the last quarter. 69.58% of the stock is currently owned by hedge funds and other institutional investors.
About HealthStream
HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.
The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.
Read More
- Five stocks we like better than HealthStream
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
- The Ugly Truth Behind SoundHound’s Q3 Results
Receive News & Ratings for HealthStream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthStream and related companies with MarketBeat.com's FREE daily email newsletter.
